001451610 000__ 05762cam\a2200589\a\4500
001451610 001__ 1451610
001451610 003__ OCoLC
001451610 005__ 20230310004708.0
001451610 006__ m\\\\\o\\d\\\\\\\\
001451610 007__ cr\un\nnnunnun
001451610 008__ 221203s2022\\\\sz\\\\\\o\\\\\000\0\eng\d
001451610 019__ $$a1352417813$$a1354208120
001451610 020__ $$a9783031087745$$q(electronic bk.)
001451610 020__ $$a3031087747$$q(electronic bk.)
001451610 020__ $$z9783031087738
001451610 020__ $$z3031087739
001451610 0247_ $$a10.1007/978-3-031-08774-5$$2doi
001451610 035__ $$aSP(OCoLC)1352969516
001451610 040__ $$aEBLCP$$beng$$cEBLCP$$dGW5XE$$dEBLCP$$dYDX$$dUKAHL$$dOCLCQ$$dOCLCF
001451610 049__ $$aISEA
001451610 050_4 $$aRC349.D52
001451610 08204 $$a616.80475$$223/eng/20221216
001451610 24500 $$aNeuroimaging pharmacopoeia /$$cDaniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer, editors.
001451610 250__ $$a2nd ed.
001451610 260__ $$aCham :$$bSpringer,$$c2022.
001451610 300__ $$a1 online resource (413 p.)
001451610 500__ $$a20.2 Mechanism
001451610 5050_ $$aIntro -- Contents -- Part I: Drugs and Alcohol -- 1: Tobacco -- 1.1 Uses -- 1.2 Mechanism -- 1.3 Imaging Findings -- 1.3.1 Stroke -- 1.3.2 Cerebral Aneurysm -- 1.3.3 Cerebral Venous Thrombosis -- 1.3.4 Head and Neck Cancer, Squamous Cell Carcinoma -- 1.3.5 Brain Metastases -- 1.3.6 Warthin Tumor -- 1.3.7 Smoking-Induced Nasopharyngeal Lymphoid Hyperplasia -- Suggested Reading -- 2: Alcohol -- 2.1 Uses -- 2.2 Mechanism -- 2.3 Imaging Findings -- Suggested Reading -- 3: Methanol -- 3.1 Uses -- 3.2 Mechanism -- 3.3 Imaging Findings -- 3.4 Differential Diagnosis
001451610 5058_ $$aSuggested Reading -- 4: Cannabis (Marijuana) -- 4.1 Uses -- 4.2 Mechanism -- 4.3 Imaging Findings -- 4.4 Differential Diagnosis -- Suggested Reading -- 5: Synthetic Cannabinoids -- 5.1 Uses -- 5.2 Mechanism -- 5.3 Imaging Findings -- 5.4 Differential Diagnosis -- Suggested Reading -- 6: Crack and Cocaine -- 6.1 Uses -- 6.2 Mechanism -- 6.3 Imaging Findings -- 6.4 Differential Diagnosis -- Suggested Reading -- 7: Amphetamines -- 7.1 Uses -- 7.2 Mechanism -- 7.3 Imaging Findings -- 7.4 Differential Diagnosis -- Suggested Reading -- 8: Opioids -- 8.1 Uses -- 8.2 Mechanism
001451610 5058_ $$a8.3 Imaging Findings -- 8.4 Differential Diagnosis -- Suggested Reading -- 9: Betel Nuts -- 9.1 Uses -- 9.2 Mechanism -- 9.3 Imaging Findings -- 9.4 Differential Diagnosis -- Suggested Reading -- 10: Licorice -- 10.1 Uses -- 10.2 Mechanism -- 10.3 Imaging Findings -- 10.4 Differential Diagnosis -- Suggested Reading -- 11: Centella asiatica -- 11.1 Uses -- 11.2 Mechanism -- 11.3 Imaging Findings -- 11.4 Differential Diagnosis -- Suggested Reading -- Part II: Contrast Agents -- 12: Iodinated Contrast Agents -- 12.1 Uses -- 12.2 Mechanism -- 12.3 Imaging Findings
001451610 5058_ $$a12.4 Differential Diagnosis -- Suggested Reading -- 13: Gadolinium-Based Contrast Agents -- 13.1 Uses -- 13.2 Mechanism -- 13.3 Imaging Findings -- 13.4 Differential Diagnosis -- Suggested Reading -- 14: Ferumoxytol -- 14.1 Uses -- 14.2 Mechanism of Action -- 14.3 Imaging Findings -- 14.4 Differential Diagnosis -- Suggested Reading -- 15: Pantopaque (Myodil, Iodophenylundecylic Acid) -- 15.1 Uses -- 15.2 Mechanism -- 15.3 Imaging Findings -- 15.4 Differential Diagnosis -- Suggested Reading -- 16: Thorium Dioxide (Thorotrast) -- 16.1 Uses -- 16.2 Mechanism -- 16.3 Imaging Findings
001451610 5058_ $$a16.4 Differential Diagnosis -- Suggested Reading -- Part III: Chemotherapy -- 17: Temozolamide (Temodar) -- 17.1 Uses -- 17.2 Mechanism -- 17.3 Imaging Findings -- 17.4 Differential Diagnosis -- Suggested Reading -- 18: 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU -- Carmustine) Polymer Wafer (Gliadel) -- 18.1 Uses -- 18.2 Mechanism -- 18.3 Imaging Findings -- 18.4 Differential Diagnosis -- Suggested Reading -- 19: Methotrexate -- 19.1 Uses -- 19.2 Mechanism -- 19.3 Imaging Findings -- 19.4 Differential Diagnosis -- Suggested Reading -- 20: 5-Fluorouracil -- 20.1 Uses
001451610 506__ $$aAccess limited to authorized users.
001451610 520__ $$aThis book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The books closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. .
001451610 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 16, 2022).
001451610 650_0 $$aNervous system$$xImaging$$vCase studies.
001451610 650_0 $$aNervous system$$xDiseases$$xDiagnosis$$vCase studies.
001451610 650_0 $$aNervous system$$xDiseases$$xTreatment.
001451610 650_0 $$aPharmacopoeias.
001451610 650_0 $$aDiagnosis, Differential.
001451610 655_0 $$aElectronic books.
001451610 655_7 $$aCase studies.$$2fast$$0(OCoLC)fst01423765
001451610 7001_ $$aGinat, Daniel Thomas.
001451610 7001_ $$aSmall, Juan E.
001451610 7001_ $$aSchaefer, Pamela W.
001451610 77608 $$iPrint version:$$aGinat, Daniel Thomas$$tNeuroimaging Pharmacopoeia$$dCham : Springer International Publishing AG,c2023$$z9783031087738
001451610 852__ $$bebk
001451610 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-08774-5$$zOnline Access$$91397441.1
001451610 909CO $$ooai:library.usi.edu:1451610$$pGLOBAL_SET
001451610 980__ $$aBIB
001451610 980__ $$aEBOOK
001451610 982__ $$aEbook
001451610 983__ $$aOnline
001451610 994__ $$a92$$bISE